Next Article in Journal
Radiation Recall Dermatitis with Azithromycin
Previous Article in Journal
Access to Thalidomide for the Treatment of Multiple Myeloma in Canada: Physician Behaviours and Ethical Implications
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Current Oncology
Volume 17
Issue 4
10.3747/co.v17i4.691
curroncol-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
Current Oncology is published by MDPI from Volume 28 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Multimed Inc..
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Meeting Report

BONUS 5: 5th Annual Bone and The Oncologist New Updates

by
N. Bouganim
1,*,
E. Amir
2 and
M. Clemons
3
1
Division of Medical Oncology, Segal Cancer Center, McGill University, Montreal, QC, Canada
2
Division of Medical Oncology, The Ottawa Hospital Cancer Centre, University of Ottawa, Ottawa, ON, Canada
3
Division of Hematology and Oncology, The Princess Margaret Hospital, University of Toronto, Toronto, ON, Canada
*
Author to whom correspondence should be addressed.
Curr. Oncol. 2010, 17(4), 113-118; https://doi.org/10.3747/co.v17i4.691
Submission received: 8 May 2010 / Revised: 5 June 2010 / Accepted: 4 July 2010 / Published: 1 August 2010

Abstract

The 5th annual Bone and The Oncologist New Updates (BONUS 5) conference, held at the National Arts Center, Ottawa, April 8–9, 2010, focused on innovative research into the mechanisms and consequences of increased bone turnover in the benign and metastatic settings alike. This year there was also a debate over the controversial use of bisphosphonates as an adjuvant treatment in patients with early-stage breast cancer. This meeting report highlights a few of the topics presented.
Keywords: bone; breast cancer; prostate cancer bone; breast cancer; prostate cancer

Share and Cite

MDPI and ACS Style

Bouganim, N.; Amir, E.; Clemons, M. BONUS 5: 5th Annual Bone and The Oncologist New Updates. Curr. Oncol. 2010, 17, 113-118. https://doi.org/10.3747/co.v17i4.691

AMA Style

Bouganim N, Amir E, Clemons M. BONUS 5: 5th Annual Bone and The Oncologist New Updates. Current Oncology. 2010; 17(4):113-118. https://doi.org/10.3747/co.v17i4.691

Chicago/Turabian Style

Bouganim, N., E. Amir, and M. Clemons. 2010. "BONUS 5: 5th Annual Bone and The Oncologist New Updates" Current Oncology 17, no. 4: 113-118. https://doi.org/10.3747/co.v17i4.691

APA Style

Bouganim, N., Amir, E., & Clemons, M. (2010). BONUS 5: 5th Annual Bone and The Oncologist New Updates. Current Oncology, 17(4), 113-118. https://doi.org/10.3747/co.v17i4.691

Article Metrics

Back to TopTop